Fight CRC Blog

What We Learned at ESMO GI 2025 About Botensilimab + Balstilimab

Honestly, you can’t watch TV or scroll Instagram without seeing a commercial about Ozempic®, Wegovy®, Mounjaro® or a compounded semaglutide right now. These drugs were developed to manage type 2...

GLP-1s and Colorectal Cancer: What You Need to Know

Honestly, you can’t watch TV or scroll Instagram without seeing a commercial about Ozempic®, Wegovy®, Mounjaro® or a compounded semaglutide right now. These drugs were developed to manage type 2...

29 Organizations Applaud Continued Access to Colorectal Cancer Screenings

leading patient advocacy groups and healthcare organizations joined together to applaud the United States Supreme Court’s decision in Braidwood v. Kennedy to uphold the constitutionality of the United States Preventive...

Letter to Secretary Kennedy

On behalf of the colorectal cancer community including patients, families, researchers, and healthcare providers across the nation, we write to emphasize the concerns you raised in your recent appearances before...

Patient Stories: How biomarker testing impacted their cancer treatment

Tumor testing, genomic testing, biomarker testing – these are all complicated names for the same thing. Regardless of how you refer to it, biomarker testing plays an important role in...

Research to Watch at ASCO 2025

Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings groundbreaking research to the forefront — and this year is no exception. At ASCO 2025, several clinical trials...